Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan.
Abstract
This study examined polymorphisms in the dihydrofolate reductase (DHFR) gene of Pneumocystis carinii isolates from 27 patients with P. carinii pneumonia (PCP) in Japan. Four substitution sites with two synonymous and two non-synonymous changes were found. Two synonymous substitutions at nucleotide positions 540 and 312 were identified in one and 13 patients, respectively. Two amino acid substitutions (Ala67Val, Cysl66Tyr) were found in two different patients. No linkage of amino acid substitutions in DHFR to those in dihydropteroate synthase was observed. The two patients whose isolates showed non-synonymous DHFR mutations were not exposed to DHFR inhibitors before they developed PCP and were treated successfully with co-trimoxazole.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Two studies have failed to demonstrate an association between the use of TMP-SMX for PCP prophylaxis in HIV-infected persons and the presence of DHFR gene mutations.
“To date, two studies have failed to demonstrate an association between the use of TMP-SMX for PCP prophylaxis in HIV-infected persons and the presence of DHFR gene mutations (21,36).”
From Dihydropteroate Synthase Gene Mutations in<i>Pneumocystis</i>and Sulfa Resistance (2004) · cites this paper as [36]
In the second study, 16 (59%) of 27 specimens had DHFR gene mutations, 14 had synonymous changes, and 2 had nonsynonymous changes.
“In the second study, 16 (59%) of 27 specimens (from 27 patients, 19 of whom were HIV-infected) had DHFR gene mutations, 14 had synonymous changes, and 2 had nonsynonymous changes (36).”
From Dihydropteroate Synthase Gene Mutations in<i>Pneumocystis</i>and Sulfa Resistance (2004) · cites this paper as [36]
This study reported that observed nonsynonymous changes in Pneumocystis DHFR were not in the highly conserved regions of the enzyme as are the amino acid substitutions that confer resistance to TMP (or pyrimethamine) in E. coli, Staphylococcus aureus, Streptococcus pneumoniae, and Plasmodium falciparum.
“In addition, this study aligned the Pneumocystis DHFR sequences with those of E. coli, Staphylococcus aureus, Streptococcus pneumoniae, and Plasmodium falciparum and reported that the observed nonsynonymous changes in Pneumocystis DHFR were not in the highly conserved regions of the enzyme as are the amino acid substitutions that confer resistance to TMP (or pyrimethamine) in these other organisms”
From Dihydropteroate Synthase Gene Mutations in<i>Pneumocystis</i>and Sulfa Resistance (2004) · cites this paper as [36]
Neither of the two patients whose PCP specimen had nonsynonymous DHFR changes had prior exposure to DHFR inhibitors, yet both patients were treated successfully for PCP with TMP-SMX.
“Neither of the two patients whose PCP specimen had nonsynonymous DHFR changes had prior exposure to DHFR inhibitors, yet both patients were treated successfully for PCP with TMP-SMX.”
From Dihydropteroate Synthase Gene Mutations in<i>Pneumocystis</i>and Sulfa Resistance (2004) · cites this paper as [36]
Cites
Genome sequence of enterohaemorrhagic Escherichia coli O157:H7
Perna, N. T., Plunkett, G., Burland, V., Mau, B., Glasner, J. D., Rose, D. J., Mayhew, G. F., Evans, P. S., Gregor, J., Kirkpatrick, H. A., et al. (2001) · Nature · doi:10.1038/35054089 · Cited by 2,035 · see citing works
Prosite: a dictionary of sites and patterns in proteins
Bairoch, A. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.suppl.2013 · Cited by 930 · see citing works
Peterson, D. S., Walliker, D., & Wellems, T. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.9114 · Cited by 656 · see citing works
Gagnon, S., Boota, A. M., Fischl, M. A., Baier, H., Kirksey, O. W., & Voie, L. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011223232103 · Cited by 371 · see citing works
PNEUMOCYSTIS CARINII PNEUMONIA
Botella, F. G., Jv, B. M., Gómez, M. L., Sempere, G., Escarti, R. M., & Fuster, M. J. G. (1964) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb109524.x · Cited by 312 · see citing works
Weverling, G. J., Mocroft, A., Ledergerber, B., Kirk, O., Gonzales-Lahoz, J., Monforte, A. D., Proenca, R., Phillips, A. N., Lundgren, J. D., & Reiss, P. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03287-0 · Cited by 220 · see citing works
Dale, G. E., Broger, C., Arcy, A. D., HARTMAN, P. G., DeHoogt, R., Jolidon, S., Kompis, I. M., Labhardt, A. M., Langen, H., Locher, H. H., et al. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0770 · Cited by 177 · see citing works
Dihydropteroate synthase polymorphisms in Pneumocystis carinii.
Lane, B. R., Ast, J. C., Hossler, P. A., Mindell, D. P., Bartlett, M. S., Smith, J. W., & Meshnick, S. R. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.2.482 · Cited by 176 · see citing works
Ma, L., Borio, L., Masur, H., & Kovacs, J. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/315148 · Cited by 169 · see citing works
Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene.
Edman, J. C., Edman, U., Cao, M., Lundgren, B., Kovacs, J. A., & Santi, D. V. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8625 · Cited by 147 · see citing works
Pikis, A., Donkersloot, J. A., Rodriguez, W. J., & Keith, J. M. (1998) · The Journal of Infectious Diseases · doi:10.1086/515371 · Cited by 72 · see citing works
Takahashi, T., Hosoya, N., Endo, T., Nakamura, T., Sakashita, H., Kimura, K., Ohnishi, K., Nakamura, Y., & Iwamoto, A. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.9.3161-3164.2000 · Cited by 69 · see citing works
Coque, T. M., Singh, K. V., Weinstock, G. M., & Murray, B. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.141 · Cited by 60 · see citing works
Gangjee, A., Guo, X., Queener, S. F., Cody, V., Galitsky, N., Luft, J. R., & Pangborn, W. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970537w · Cited by 34 · see citing works
Ma, L., & Kovacs, J. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3092-3096.2000 · Cited by 31 · see citing works
Rosowsky, A., Papoulis, A. T., & Queener, S. F. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970614n · Cited by 23 · see citing works
Hosoya, N., Takahashi, T., WADA, M., Endo, T., Nakamura, T., Sakashita, H., Kimura, K., Ohnishi, K., Nakamura, Y., Mizuochi, T., et al. (2000) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2000.tb02538.x · Cited by 18 · see citing works
Amit, Z., & Kaneshiro, E. S. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.3.1137-1139.2001 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
DNA and RNA Synthesis: Antifolates
Kompis, I. M., Islam, K., & Then, R. L. (2005) · Chemical Reviews · doi:10.1021/cr0301144 · Cited by 231 · see citing works
HIV-Associated <i>Pneumocystis</i> Pneumonia
Huang, L., Cattamanchi, A., Davis, J. L., Boon, S. D., Kovacs, J., Meshnick, S., Miller, R. F., Walzer, P. D., Worodria, W., & Masur, H. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201009-062wr · Cited by 191 · see citing works
Epidemiology of fungal infections in China
Chen, M., Xu, Y., Hong, N., Yang, Y., Lei, W., Du, L., Zhao, J., Lei, X., Xiong, L., Cai, L., et al. (2018) · Frontiers of Medicine · doi:10.1007/s11684-017-0601-0 · Cited by 137 · see citing works
Dihydropteroate Synthase Gene Mutations in<i>Pneumocystis</i>and Sulfa Resistance
Huang, L., Crothers, K., Atzori, C., Benfield, T., Miller, R., Rabodonirina, M., & Helweg-Larsen, J. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1010.030994 · Cited by 131 · see citing works
“To date, two studies have failed to demonstrate an association between the use of TMP-SMX for PCP prophylaxis in HIV-infected persons and the presence of DHFR gene mutations (21,36).”
BackgroundMutations of Pneumocystis jirovecii Dihydrofolate Reductase Associated with Failure of Prophylaxis
Nahimana, A., Rabodonirina, M., Billé, J., Francioli, P. B., & Hauser, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4301-4305.2004 · Cited by 94 · see citing works
A Molecular Window into the Biology and Epidemiology of Pneumocystis spp
Ma, L., Cissé, O. H., & Kovacs, J. A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-18 · Cited by 94 · see citing works
Queener, S. F., Cody, V., Pace, J., Torkelson, P., & Gangjee, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01161-13 · Cited by 51 · see citing works
Goto, N., Takahashi-Nakazato, A., Futamura, K., Okada, M., Yamamoto, T., Tsujita, M., Hiramitsu, T., Narumi, S., Tsuchiya, K., Gatanaga, H., et al. (2017) · Transplantation Direct · doi:10.1097/txd.0000000000000665 · Cited by 29 · see citing works
Robberts, F. J. L., Chalkley, L. J., Weyer, K., Goussard, P., & Liebowitz, L. D. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.3.1443-1444.2005 · Cited by 28 · see citing works
Towards New Antifolates Targeting Eukaryotic Opportunistic Infections
Liu, J., Bolstad, D. B., Bolstad, E. S. D., Wright, D. L., & Anderson, A. C. (2009) · Eukaryotic Cell · doi:10.1128/ec.00298-08 · Cited by 28 · see citing works
Costa, M. C., Esteves, F., Antunes, F., & Matos, O. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl411 · Cited by 27 · see citing works
Study of DHPS and DHFR genes ofPneumocystis jiroveciiin Thai HIV-infected patients
Siripattanapipong, S., Leelayoova, S., Mungthin, M., Worapong, J., & Tan‐ariya, P. (2008) · Medical Mycology · doi:10.1080/13693780701883722 · Cited by 24 · see citing works
Muñoz, C. O., Zuluaga, A., Restrepo, Á., Tobón, Á. M., Cano, L. E., & González, Á. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.11.015 · Cited by 16 · see citing works
Jarboui, M. A., Mseddi, F., Sellami, H., Sellami, A., Makni, F., & Ayadi, A. (2012) · Medical Mycology · doi:10.3109/13693786.2012.744879 · Cited by 16 · see citing works
Deng, X., Li, Z., Lan, Y., Dai, Z., Chen, W., Cai, W., Kovacs, J. A., Ma, L., & Tang, X. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01848-14 · Cited by 12 · see citing works
Recommendations for the treatment of fungal pneumonias
Yamada, H., Kotaki, H., & Takahashi, T. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.8.1241 · Cited by 12 · see citing works
Mane, A. K., Gujar, P., Chandra, J., Lokhande, R., Dhamgaye, T. M., Ghorpade, S., & Risbud, A. (2014) · Mycopathologia · doi:10.1007/s11046-014-9818-5 · Cited by 10 · see citing works
Pneumocystis jirovecii Dihydrofolate Reductase Polymorphisms Associated with Failure of Prophylaxis
Nahimana, A., Rabodonirina, M., Francioli, P. B., Billé, J., & Hauser, P. M. (2003) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2003.tb00673.x · Cited by 9 · see citing works
Singh, Y., Mirdha, B. R., Guleria, R., Khalil, S., Panda, A., Chaudhry, R., Mohan, A., Kabra, S. K., Kumar, L., & Agarwal, S. K. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6810 · Cited by 9 · see citing works
Multilocus Genotyping of Pneumocystis jirovecii in Immunocompromised Patients: Preliminary Results
Costa, M. C., Esteves, F., Antunes, F., & Matos, O. (2006) · Journal of Eukaryotic Microbiology · doi:10.1111/j.1550-7408.2006.00190.x · Cited by 6 · see citing works
Xue, T., Du, W.-Q., Dai, W.-J., Li, Y., Wang, S., Wang, J., & Zhang, X. (2022) · Polish Journal of Microbiology · doi:10.33073/pjm-2022-002 · Cited by 6 · see citing works
Drug Resistance in Pneumocystis jirovecii
Helweg‐Larsen, J., Benfield, T., Kovacs, J. A., & Masur, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_22 · Cited by 2 · see citing works
Mutations of Drug Target Molecules in Pneumocystis jirovecii Isolates and Future Investigations
Takahashi, T. (2009) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.50.067 · Cited by 2 · see citing works
Bonnet, P. L., Gal, S. L., Gautier, C., Hoffmann, C. V., Nan, N. L., Happe, A., Berre, R. L., Saraux, A., & Nevez, G. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00990-22 · Cited by 1 · see citing works
Pneumocystis: An Atypical Fungal Pathogen
Ma, L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05473-8 · Cited by 1 · see citing works
Smulian, A. G., & Cushion, M. T. (2014) · ASM Press eBooks · doi:10.1128/9781555815776.ch25 · Cited by 1 · see citing works
Robberts, F. J. L. (2005) · SUNScholar (Stellenbosch University) · Cited by 1 · see citing works
NEONATAL IMMUNE MODULATION TO IMPROVE PNEUMOCYSTIS CLEARANCE
Empey, K. M. (2007) · UKnowledge (University of Kentucky)
Drug Resistance in Pneumocystis jirovecii
Helweg‐Larsen, J., Benfield, T., Kovacs, J. A., & Masur, H. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-595-8_22
Dihydropteroate Synthase Gene Mutations in Pneumocystis and
Resistance, S., Huang, L., Crothers, K. A., Atzori, C., Benfield, T., Miller, R. F., Rabodonirina, M., & Helweg‐Larsen, J. (2004)
Genotyping Pneumocystis jirovecii: Impacting Our Understanding of Interhuman Transmission
Gits‐Muselli, M., Bretagne, S., & Alanio, A. (2019) · OBM Genetics · doi:10.21926/obm.genet.1901060
- Authors
- TAKAHASHI, T., ENDO, T., NAKAMURA, T., SAKASHITA, H., KIMURA, K., OHNISHI, K., KITAMURA, Y., & IWAMOTO, A.
- Affiliations
- Tokyo Metropolitan Bokutoh Hospital (JP)
- Venue
- Journal of Medical Microbiology
- Publisher
- Microbiology Society
- Published
- 2002-06-01
- Volume
- 51
- Issue
- 6
- Pages
- 510-515
- ISSN
- 0022-2615 (ISSN-L)
- 1473-5644
- OpenAlex
- W2101386304
- Cited by
- 31
- References
- 18
- Citations by year
- 2022: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2015: 2 · 2014: 3 · 2013: 1 · 2012: 2
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medical Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumocystis jirovecii pneumonia detection and treatment
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Life Sciences › Immunology and Microbiology › Parasitology › Parasitic Infections and Diagnostics
- Keywords
- dihydrofolate reductase, Pneumocystis carinii pneumonia, synonymous substitutions, amino acid substitutions, dihydropteroate synthase, drug resistance, Japan
- MeSH terms
- Amino Acid Sequence, Anti-Infective Agents, Base Sequence, Bronchoalveolar Lavage Fluid, Dihydropteroate Synthase, Gene Amplification, Genes, Fungal, Humans, Japan, Molecular Sequence Data, Mutation, Pneumocystis, Pneumonia, Pneumocystis, Polymorphism, Genetic, Tetrahydrofolate Dehydrogenase, Trimethoprim, Sulfamethoxazole Drug Combination, Polymerase Chain Reaction, Sequence Alignment, Immunocompromised Host, Treatment Failure, Sequence Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review